MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/09691413221090739

Медицинская библиотека · Journal of medical screening · 2022

Screen-detected ductal carcinoma in situ, 2008-2020: An observational study.

Kelly Caitriona, Fitzpatrick Patricia, Quinn Cecily, Flanagan Fidelma, Connors Alissa, Larke Aideen, Mooney Therese, Kennedy Maria, Sheehan Margaret, Bennett Michael W, Brodie Caroline, O'Doherty Ann

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

The purpose of this study was to evaluate the grade distribution of screen-detected ductal carcinoma in situ (DCIS) diagnosed in Ireland, in the context of the clinical trials currently underway to determine if active surveillance is a feasible management option for low-risk DCIS.

SETTING

BreastCheck is the national breast screening programme in Ireland, offering screening to women aged 50 to 69 every two years.

METHODS

This study was a secondary analysis of data collected by BreastCheck on all screen-detected DCIS diagnosed in the 12 years of nationwide screening. Incidence and detection rates were calculated. Descriptive analysis of the cases was performed and, for comparative analysis, grade of DCIS was analysed as a binary variable (high vs. low/intermediate) in keeping with the inclusion criteria for active surveillance trials. Analysis was performed in IBM Statistical Package for Social Sciences, version 26.

RESULTS

Between 2008 and 2020, 2240 women were diagnosed with DCIS through BreastCheck; 876 (39.1%) were low/intermediate-grade. The overall incidence rate has remained relatively stable during this period. Women with low/intermediate-grade DCIS were younger than women with high-grade DCIS (56 (interquartile range: 56-61) years v 57 (interquartile range: 53-61) years; p < 0.001). They were also more likely to have been diagnosed at an initial screening episode compared with those who had high-grade lesions (42.5% v 29.0%; p < 0.001).

CONCLUSION

If current clinical trials recommend active surveillance as a feasible option for DCIS, up to 40% of women with screen-detected DCIS may be eligible. These women are younger and often diagnosed on initial screening episode, so may require longer active follow-up.

Для цитирования: Kelly Caitriona, Fitzpatrick Patricia, Quinn Cecily, Flanagan Fidelma, Connors Alissa, Larke Aideen, Mooney Therese, Kennedy Maria, Sheehan Margaret, Bennett Michael W, Brodie Caroline, O'Doherty Ann. Screen-detected ductal carcinoma in situ, 2008-2020: An observational study.. Journal of medical screening. 2022. DOI: 10.1177/09691413221090739.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.